| Shilpa Doogal, MD | |
|
275 Varnum Ave, Suite 203, Lowell, MA 01854-2141 | |
| (978) 934-9220 | |
| (978) 453-7771 |
| Full Name | Shilpa Doogal |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 275 Varnum Ave, Lowell, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316932858 | NPI | - | NPPES |
| 456556 | Other | MA | TUFTS |
| AA37884 | Other | MA | HARVARD PILGRIM |
| J23856 | Other | MA | BCBS |
| 0145131 | Medicaid | MA | |
| 2485229 | Other | MA | UNITED HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 210283 (Massachusetts) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 210283 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shilpa Doogal, MD 275 Varnum Ave, Suite 203, Lowell, MA 01854-2141 Ph: (978) 934-9220 | Shilpa Doogal, MD 275 Varnum Ave, Suite 203, Lowell, MA 01854-2141 Ph: (978) 934-9220 |
News Archive
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.
Researchers at Mount Sinai School of Medicine have used a newly discovered class of biomarkers to investigate the possibility that the shape of brain protein deposits is different in people with Alzheimer's who have the highest-risk gene type than in those with the condition who have a neutral risk gene type. The study is being presented July 14 at the 2010 Alzheimer's Association International Conference on Alzheimer's Disease in Honolulu, Hawaii.
A new study conducted by researchers at Florida International University, Miami, has found that communities in the United States with a high density of African Americans are disproportionately burdened with the adverse outcomes of coronavirus disease 2019 (COVID-19).
Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.
› Verified 4 days ago
Alexandra Miniati, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Riverside Medical Group, Ste 201, Lowell, MA 01854 Phone: 978-452-9700 Fax: 978-441-6075 | |
Dr. Cynthia Lynn Manning, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6439 | |
Mrs. Frances M Morse, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 275 Varnum Ave, Ste 101, Lowell, MA 01854 Phone: 978-459-0531 Fax: 978-459-8389 | |
Mrs. Sara Larson Clay, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave, Ste 201, Lowell, MA 01854 Phone: 978-452-9700 Fax: 978-441-6075 | |
Riad Ettunsi, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 | |
Peter S Bradshaw, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 77 E Merrimack St, Suite 15, Lowell, MA 01852 Phone: 978-459-3341 | |
Seema Sahib, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave # General, Lowell, MA 01854 Phone: 978-937-6439 |